This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Investors
Financial results and information
Beamtree’s products and services have created value and helped solve global healthcare problems using data, insight and pioneering technology for more than two decades. Find out more about our company below, including our latest annual reports and investor presentations.
Learn more about BeamtreeReports
-
Beamtree Annual Report 2024
-
Beamtree Interim Report FY24
-
Beamtree Annual Report 2023
-
Beamtree Interim Report FY23
-
Beamtree Annual Report 2022
-
Beamtree Half Year Report 2022
-
Beamtree Annual Report 2021
-
PKS Annual Report 2020
-
PKS Annual Report 2019
ASX Releases
Date
-
FY24 Beamtree AGM Slide Deck
28 November 2024
-
241015 BMT - CEO resignation - for lodgement
17 October 2024
-
Major recurring revenue contract win in Saudi Arabia
25 September 2024
-
FY24 Investor Webinar Recording
29 August 2024
-
FY24 Results Investor Presentation
27 August 2024
-
FY24 Results Announcement
27 August 2024
-
Appendix 4G and Corporate Governance Statement
27 August 2024
-
FY24 Annual Report
27 August 2024
-
Preliminary Final Report
27 August 2024
-
FY24 Unaudited Annual Results - Investor Presentation
6 August 2024
-
Unaudited FY24 results, strong cashflow & good FY25 outlook
6 August 2024
-
Beamtree wins AU$3.6m contract in Saudi Arabia
27 May 2024
-
Change of Director's Interest Notice - E Gray
14 May 2024
-
Initial Director's Interest Notice - M Britnell
8 May 2024
-
Becoming a substantial holder
7 May 2024
-
Board Chair increases interest in Beamtree to 10.65%
7 May 2024
-
Cleansing Notice
1 May 2024
-
Application for quotation of securities - BMT
1 May 2024
-
International health leader joins Beamtree board
1 May 2024
-
Q3 FY24 Trading Update
1 May 2024
-
Change of Director's Interest Notice - J Birch
10 April 2024
-
Change of Director's Interest Notice - B Lancken
10 April 2024
-
Change of Director's Interest Notice - M Hill
10 April 2024
-
Change of Director's Interest Notice - E Gray
10 April 2024
-
Cleansing Notice
9 April 2024
-
Application for quotation of securities - BMT
9 April 2024
-
Notification of Expiry of Unlisted Options
9 April 2024
-
Cleansing Notice
28 March 2024
-
Application for quotation of securities - BMT
28 March 2024
-
Change of Director's Interest Notice - M Hill
28 March 2024
-
Change of Registered Office and Principal Place of Business
11 March 2024
-
Notification of cessation of securities - BMT
16 February 2024
-
1H FY24 Investor Webinar Record
15 February 2024
-
1H FY24 Results and Trading Update
14 February 2024
-
1H FY24 Investor Presentation
14 February 2024
-
Appendix 4D and FY24 Interim Report
14 February 2024
-
Beamtree 1H FY24 Results and Investor Webinar
25 January 2024
-
Change in substantial holding from MIR
25 January 2024
-
Application for quotation of securities - BMT
16 January 2024
-
Final Director's Interest Notice - S Borness
4 January 2024
-
Resignation of Non-Executive Director - Stephen Borness
2 January 2024
-
Change of Director's Interest Notice - B Lancken
22 December 2023
-
Change of Director's Interest Notice - J Birch
22 December 2023
-
Change of Director's Interest Notice - E Gray
22 December 2023
-
Cleansing Notice
22 December 2023
-
Application for quotation of securities - BMT
22 December 2023
-
Application for quotation of securities - BMT
22 December 2023
-
Product Demonstration Webinar Recording
22 November 2023
-
Results of Annual General Meeting
21 November 2023
-
Annual General Meeting Addresses and Presentation
21 November 2023
-
Product Demonstration - updated link
20 November 2023
-
Issue of Performance Rights to Executives
17 November 2023
-
Notification regarding unquoted securities - BMT
17 November 2023
-
Notification regarding unquoted securities - BMT
17 November 2023
-
Beamtree AGM Product Demonstration
15 November 2023
-
Application for quotation of securities
31 October 2023
-
Application for quotation of securities
31 October 2023
-
Cleansing Notice
31 October 2023
-
Q1 FY24 Trading Update
27 October 2023
-
Notice of Annual General Meeting/Proxy Form
20 October 2023
-
Application for quotation of securities
12 October 2023
-
Application for quotation of securities
28 September 2023
-
Change of Director's Interest Notice - M Hill
5 September 2023
-
FY23 Investor Webinar Record
29 August 2023
-
Cleansing Notice
28 August 2023
-
Application for quotation of securities
28 August 2023
-
FY23 Results Announcement
24 August 2023
-
FY23 Investor Presentation
24 August 2023
-
Appendix 4G and Corporate Governance Statement
24 August 2023
-
FY23 Annual Report
24 August 2023
-
Preliminary Final Report
24 August 2023
-
Beamtree Full Year Results and Investor Webinar
16 August 2023
-
Q4 FY23 Trading Update
27 July 2023
-
Application for quotation of securities
13 July 2023
-
Cleansing Notice
6 July 2023
-
Application for quotation of securities
6 July 2023
-
Cleansing Notice
26 June 2023
-
Application for quotation of securities
26 June 2023
-
Change in substantial holding
23 June 2023
-
Application for quotation of securities
8 June 2023
-
Beamtree secures first contract in Canada
8 June 2023
-
Application for quotation of securities - BMT
6 June 2023
-
Cleansing Notice
6 June 2023
-
Proposed issue of securities - BMT
29 May 2023
-
Beamtree completes $5m capital raise
29 May 2023
-
Trading Halt
25 May 2023
-
Application for quotation of securities - BMT
28 April 2023
-
Q3 FY23 Trading Update Presentation
27 April 2023
-
Q3 FY23 Trading Update
27 April 2023
-
Cleansing Notice
20 March 2023
-
Application for quotation of securities - BMT
20 March 2023
-
Application for quotation of securities - BMT
15 March 2023
-
Change of Director's Interest Notice - M Hill
10 March 2023
-
1H FY23 Investor Webinar Record
16 February 2023
-
1H FY23 Trading Highlights
15 February 2023
-
Appendix 4D and FY23 Interim Report
15 February 2023
-
1H FY23 Investor Presentation
15 February 2023
-
Beamtree 1H FY23 Results and Investor Webinar
1 February 2023
-
BMT agrees revised contract terms Health Roundtable Limited
31 January 2023
-
Notification regarding unquoted securities - BMT
24 January 2023
-
Clarification of contract with Abbott
16 December 2022
-
Beamtree agrees new global contract with Abbott
16 December 2022
-
Initial Director's Interest Notice - E Gray
30 November 2022
-
Final Director's Interest Notice - P Williams
30 November 2022
-
Final Director's Interest Notice - A Gray
30 November 2022
-
Annual General Meeting Webinar Record
29 November 2022
-
Amended Constitution
25 November 2022
-
Results of Annual General Meeting
24 November 2022
-
Annual General Meeting Addresses and Presentation
24 November 2022
-
Annual General Meeting Webinar
23 November 2022
-
Beamtree Trading Update
31 October 2022
-
Notice of Annual General Meeting Proxy Form
25 October 2022
-
Change of Director's Interest Notice
21 October 2022
-
Cleansing Notice
20 October 2022
-
Application for quotation of securities
20 October 2022
-
Notification regarding unquoted securities
20 October 2022
-
Beamtree announces partnership in Kingdom of Saudi Arabia
11 October 2022
-
Appointment to Beamtree Board Mrs Emma Gray
5 October 2022
-
Notification of cessation of securities - BMT
30 September 2022
-
Change of Director's Interest Notice - M Hill
21 September 2022
-
Notice under ASX Listing Rule 3.10A
21 September 2022
-
Notification of cessation of securities - BMT
1 September 2022
-
Change of Director's Interest Notice - M Hill
29 August 2022
-
FY22 Results Announcement
24 August 2022
-
FY22 Investor Presentation
24 August 2022
-
Appendix 4G and Corporate Governance Statement
24 August 2022
-
FY22 Annual Report
24 August 2022
-
Preliminary Final Report
24 August 2022
-
Beamtree Full Year Results and Investor Webinar
10 August 2022
-
Beamtree Trading Update
29 July 2022
-
Confirmation of Capital Structure
20 July 2022
-
Cleansing Notice
20 July 2022
-
Application for quotation of securities - BMT
20 July 2022
-
Application for quotation of securities - BMT
20 July 2022
-
Change of Director's Interest Notice - S Borness
1 July 2022
-
Notice under ASX Listing Rule 3.10A
31 May 2022
-
BMT Business Update Presentation
17 May 2022
-
BMT Business Update
17 May 2022
-
BMT signs USD$7M 5-year contract for RippleDown Diagnostics
10 May 2022
-
Beamtree confirms key renewal
30 March 2022
-
Beamtree accelerates international growth with first NHS contracts
22 March 2022
-
Investor Presentation 1HY results and growth strategy focus
1 March 2022
-
Beamtree appoints Mark McLellan as new Chief Financial Officer
24 February 2022
-
Beamtree 1H FY22 business update and financials
15 February 2022
-
1H FY22 Investor Webinar
10 February 2022
-
Change of Director's Interest Notice - A Gray
29 November 2021
-
Change of Director's Interest Notice - M Hill
23 November 2021
-
Change of Director's Interest Notice - S Borness
10 November 2021
-
JobKeeper Payment Disclosure
10 November 2021
-
Results of Annual General Meeting
28 October 2021
-
Investor Presentation to the AGM
28 October 2021
-
Chairman and CEO Address to the AGM
28 October 2021
-
Cleansing Notice
14 October 2021
-
Application for quotation of securities - BMT
14 October 2021
-
Cleansing Notice
7 October 2021
-
Application for quotation of securities - BMT
7 October 2021
-
Clarification Statement - CALHN Strategic Partnership
1 October 2021
-
Completion of Acquisition of Potential(x)
30 September 2021
-
Cleansing Notice
30 September 2021
-
Notification regarding unquoted securities - BMT
30 September 2021
-
Application for quotation of securities - BMT
30 September 2021
-
BMT and CALHN partner to pioneer AI for safer patient care
30 September 2021
-
Notice of Annual General Meeting and Proxy Form
27 September 2021
-
Change of Director's Interest Notice - S Borness
22 September 2021
-
Change of Director's Interest Notice - M Hill
21 September 2021
-
Ceasing to be a substantial holder
10 September 2021
-
Change of Director's Interest Notice - J Birch
10 September 2021
-
Notification of cessation of securities - BMT
7 September 2021
-
Change of Director's Interest Notice - A Gray
7 September 2021
-
Change of Director's Interest Notice - J Birch
7 September 2021
-
Cleansing Notice
2 September 2021
-
Application for quotation of securities - BMT
2 September 2021
-
Ceasing to be a substantial holder
1 September 2021
-
Application for quotation of securities - BMT
31 August 2021
-
Beamtree acquisition presentation
30 August 2021
-
Proposed issue of securities - BMT
30 August 2021
-
Beamtree acquires Potential (x)
30 August 2021
-
Record FY21 results delivers sustainable growth
27 August 2021
-
Investor Webinar Notification
27 August 2021
-
Trading Halt
27 August 2021
-
Appendix 4G and Corporate Governance Statement
27 August 2021
-
Investor Presentation Financial Year 2021
27 August 2021
-
2021 Annual Report
27 August 2021
-
Preliminary Final Report
27 August 2021
-
Collaboration to Accelerate Global Health Research
25 August 2021
-
Change of Company Name and ASX Ticker
18 August 2021
-
Results of Extraordinary General Meeting
17 August 2021
-
Notice of Extraordinary General Meeting
9 July 2021
-
Change of Director's Interest Notice - A Gray
29 June 2021
-
Successful renewal of key contracts and new contract wins
29 June 2021
-
Cleansing Notice
25 June 2021
-
Application for quotation of securities - PKS
25 June 2021
-
Release of Securities from Voluntary Escrow
27 May 2021
-
Change of Director's Interest Notice - A Gray
26 April 2021
-
Becoming a substantial holder
26 April 2021
-
Change of Director's Interest Notice - S Borness
26 April 2021
-
Cleansing Statement
26 April 2021
-
Appendix 2A
26 April 2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Investor Presentations
Date
-
Annual General Meeting Addresses and Presentation
24 November 2022
-
Half Year Results Investor Presentation
15 February 2022
-
Investor Presentation to the AGM
28 October 2021
-
Beamtree Potential (x) acquisition presentation
31 August 2021
-
PKS Investor Presentation 2021
27 August 2021
-
Capital raise and 1H FY21 results – Investor Presentation
27 August 2021
-
PKS Investor Presentation 2020
28 August 2020